By B. Konrad. Averett College. 2018.

Source: Compre- hensive cervical cancer control: a guide to essential 23 purchase female cialis 10 mg on-line. Invite her to return in 2–6 weeks to be checked 39 practice safe female cialis 20 mg. Geneva: WHO buy female cialis 10mg line, 2006 for healing, and again in 6 months for a repeat VIA, Pap smear and possible colposcopy. Either use a rubber cap to seal off the hol- her to return immediately if she notes: low part of the cryoprobe during process- a. Clean and disinfect the cryoprobe and de- air-dry and then reassemble. Perform a pelvic examination to check for and regulator by wiping them with alcohol healing 2–6 weeks after the cryotherapy. At 6 and 12 months, do a VIA, Pap test or a soap and water until visibly clean colposcopy and take a biopsy if necessary. Rinse the cryotip and plastic sleeve Indications and exclusion criteria for cryotherapy thoroughly with clean water are shown in Table 1. High-level disinfect the cryotip and plastic sleeve by one of the following methods: Loop electrosurgical excision procedure (1) boil in water for 20 min; or (2) steam for 20 min; or (3) soak in chemical disin- LEEP, also called large loop excision of the trans- fectant (0. It is critical that the hollow part of the cryo- produces a constant low voltage and transmits it to tip is completely dry when next used, other- a wire loop device, which is used to remove the wise the water will freeze and the probe abnormal tissue. The loops are of very fine stainless could crack or the treatment not work steel or tungsten wire and come in different sizes 328 Cervical Cancer Prevention and Treatment Table 1 Indications and exclusion criteria for cryotherapy Eligibility criteria Exclusion criteria Positive screening test for cervical precancer Evidence or suspicion of invasive disease or glandular dysplasia Lesion small enough to be covered by the cryoprobe with The lesion extends more than 2 mm beyond the cryoprobe no more than 2 mm beyond its edges edge The lesion and all edges fully visible with no extension into Pregnancy the endocervix or onto the vaginal wall PID (until treated) Active menstruation PID, pelvic inflammatory disease Table 2 Indications and exclusion criteria for loop electrosurgical excision procedure (LEEP) Eligibility criteria Exclusion criteria A positive diagnostic test for precancer Suspicion of invasive cancer or glandular dysplasia Lesion extending <1 cm into the endocervical canal Lesion extending >1 cm into the endocervical canal, or whose distal or upper extent is not visible (these lesions are treated by cold knife conization) Cervical infection or PID (until treated or resolved) Pregnancy or delivery within the last 12 weeks Bleeding disorders PID, pelvic inflammatory disease and shapes. LEEP aims to remove both the lesion and the entire transformation zone. The tissue re- moved can be sent for examination to the histo- pathology laboratory, allowing the extent of the lesion to be assessed. Thus, LEEP serves a double purpose: it treats the lesion, and at the same time, produces a specimen for pathological examination. The procedure also has the advantage that it can be Figure 10 Excision of an ectocervical lesion with one performed under local anesthesia on an out-patient pass. Source: Comprehensive cervical cancer control: a basis. It is successful in eradicating pre-cancer in guide to essential practice. LEEP is a relatively simple surgical procedure, Indications and exclusion criteria for LEEP are but it should be performed only by a well-trained given in Table 2. LEEP is best carried out in facilities Cold knife conization is the removal of a cone- where back-up is available for management of shaped area from the cervix, including portions of potential problems. In most resource-poor coun- the outer (ectocervix) and inner cervix (endo- tries, this will limit LEEP to second-level (district cervix). Conization is recommended for the treat- hospital) facilities. Videos of LEEP can be seen at ment of dysplasia when out-patient treatment is not 329 GYNECOLOGY FOR LESS-RESOURCED LOCATIONS feasible or not accessible, and to rule out invasive pack and bladder catheter may be applied for cervical cancer. It takes less Management of complications of conization After cold than one hour. The patient may be discharged from knife conization, bleeding is the most common hospital the same or the next day. Because of pos- complication; it can occur immediately (primary sible side-effects, cold knife conization should be bleeding) or up to 14 days after the procedure reserved for cases that cannot be resolved with cry- (secondary bleeding). In either case, the patient otherapy or LEEP excision. The extent of the needs to return to the surgical facility. Secondary conization will depend on the size of the lesion and hemorrhage is usually related to local infection and, the likelihood of finding invasive cancer. The along with measures to stop the bleeding (like woman’s desire to have more children also has to suturing, vaginal packing, cauterization), treatment be taken into account, as conization may result in with antibiotics should be prescribed. Local appli- cervical stenosis or incompetence in a few women. Cold knife conization should be performed only CERVICAL CANCER by providers with surgical skills, in an equipped Over 80% of the world’s cases of cervical cancer are surgical facility. Providers are usually gynecologists diagnosed in countries without screening programs, or surgeons trained to perform the procedure and and in developed countries, the women who do to recognize and manage complications. Most women ceives general or spinal anesthesia and is put in in developing countries present with advanced lithotomy position. An Auvard speculum and an disease, often untreatable or suitable only for pallia- anterior wall speculum are inserted and the cervix tion.

As a matter of ureters buy cheap female cialis 20 mg line, vessels and nerves and should only be fact every doctor will encounter patients with attempted by experienced surgeons order 10mg female cialis fast delivery. From ultrasound-based screening studies some risk factors could be established (level of evidence 2): • Age • African ancestry • Early age at menarche (first period) • Parity purchase female cialis 20mg line. These risk factors all deal with the already men- tioned exposure to female reproductive hormones and the duration of exposure. However, they don’t explain why some women with the same risk fac- tors which are fairly common, develop fibroids and others not, and why some fibroids start to grow and Figure 1 Locations of uterine fibroids others not. Observational studies from environ- mental health registers (level of evidence 3) have MAGNITUDE OF THE PROBLEM IN LOW- found some interesting new associations or absence RESOURCE SETTINGS of association: Not much is known about the true prevalence of • No association between smoking and fibroids. First, this is due to • No association between contraceptive pills and the above-mentioned fact that most fibroids are fibroids unless used before the age of 17 years. Second, some women may have sympto- • The association with raised body mass index matic fibroids but as a result of limited availability of (BMI) was inconsistent; no association was financial resources and healthcare they never reach found for caucasian women, but a slight but a healthcare provider for examination. Third, with significant association was found for African- limited resources of healthcare systems, fibroids are American women. Thus you can assume that there is significant under-reporting of patients SYMPTOMS with fibroids on the care provider side too. A study done in a Nigerian teaching hospital showed that When considering Figure 1 it is easy to imagine patients with symptomatic fibroids constituted 9. If you consider the a list of common symptoms associated with uterine results from ultrasound-based prevalence studies fibroids: mentioned above and compare them to this figure • Increase in size and number. A uterine tumor you can appreciate that there may be a significant rapidly growing after menopause is unlikely to unmet need for treatment in low-resource settings. Around the last period, however, fibroids can grow due to an increased number of ESTABLISHED RISK FACTORS cycles without ovulation and high estrogen Generally, it is very difficult to establish risk factors levels in the body. A complete gynecological work-up should be per- • Malignant change into leiomyosarcoma (approx. This type of operation and whether it can be performed is most probably due to an expanded surface of the in your work place. To get the most information endometrial lining when a submucosal fibroid out of your work-up you should always explain to bulges into the cavity. But also an increased number the patient what you will do and why. For an exact of small dilated vessels has been found hinting to 7 description of the procedures see Chapter 1 on other altered growth factors. The extent to which fibroids alter fertility is not Abdominal palpation clear and still under discussion. Women with other- wise unexplained infertility showed better repro- Ask the patient to empty her bladder and lie down ductive outcome after myomectomy1. Most likely, on a bed or stretcher with her abdominal muscles submucosal fibroids bulging into the cavity can relaxed. Palpate the area below the umbilicus softly alter blood circulation in the stretched endo- with your fingertips as deep as the patient allows metrium above, can distort the uterine cavity or you. Try to find out if there are any areas where block the tubes if located near their inner orifice or deep palpation is not possible due to pain or if you interfere with sperm transportation. Large fibroids can feel any hard or soft resistance. If yes, figure out can interfere with the ovum pick-up mechanism. This can help you to assess the size of the uterus or a single fibroid and can already tell you whether an HISTORY TAKING operation might be difficult in cases where the As always a thorough history should be taken, uterus is not at all mobile. Be aware, however, that especially in order to assess how long the symptoms sometimes a full bladder could mimic an enlarged have already lasted. Specific questions you could uterus by pushing it upwards. Deeply palpate at the other side • Age of menarche (as a proxy indicator for a of the abdomen and then briskly let go. If this hurts, longer exposure to estrogen and progesterone the patient has peritoneal signs and might not have during the reproductive life span. Speculum examination • Actual complaints, duration of symptoms: specifically ask about bleeding pattern, pain, As the onset of fibroid-associated symptoms is rare dysmenorrhea and pressure signs. However, you should ask the patient before doing the examination. Now put the patient in the lithotomy position as described in Chapter 1 and perform a speculum examination. Try to find the cervix and assess whether it is in the midline or distorted and whether it seems shortened. If there are uterine fibroids in the lower part of the uterus they can deviate the cervix to one side or shorten it through traction.

Significant variation in the method of assessment and definition of response was most likely the reason for the wide variation 20mg female cialis visa. Effectiveness • Because no trials of effectiveness were found order 20 mg female cialis overnight delivery, observational studies were assessed for outcomes of effectiveness purchase 10mg female cialis visa. Methodologic concerns over this study suggested caution in interpretation of these findings. Emancipated living situation and level of relationship commitment was associated with response to methylphenidate. Early response to methylphenidate was negatively associated with high school graduation, however. Methodological limitations of these studies severely limited the interpretation of these findings. Again, significant methodologic limitations suggested caution in interpreting results. Efficacy and tolerability Young children (preschool age; 3-5 years) • Comparative evidence in young children was not found. Children (elementary school age; 6-12 years) Stimulants • Immediate-release compared with extended-release formulations Attention deficit hyperactivity disorder 25 of 200 Final Update 4 Report Drug Effectiveness Review Project o The evidence regarding immediate-release methylphenidate compared with methylphenidate OROS was conflicting, with 2 double-blind trials unable to identify differences, while 2 open-label studies found that methylphenidate OROS resulted in greater improvements on some but not all assessments. Overall, the studies were unable to identify differences between methylphenidate SR and immediate-release methylphenidate, and methylphenidate CD was found to be noninferior to immediate-release methylphenidate. Methodologic concerns indicate caution in interpreting this evidence. However, these results should be interpreted with caution until higher quality evidence is available. Methodologic concerns indicate caution in interpreting these findings. A difference was found up to 6 hours post dose, but methylphenidate OROS resulted in better scores later in the day; from 10 to 12 hours post dose. Evidence from short-term trials and observational studies suggested that weight loss is greater with immediate-release dextroamphetamine than immediate-release methylphenidate. Very limited evidence suggested that twice daily dosing of immediate-release mixed amphetamine salts led to higher rates of Attention deficit hyperactivity disorder 26 of 200 Final Update 4 Report Drug Effectiveness Review Project loss of appetite and sleep trouble than once daily dosing of immediate-release methylphenidate. Transient weight loss was greater with mixed amphetamine salts and dextroamphetamine SR than with immediate-release dextroamphetamine. However, this evidence should be interpreted with caution. Rates of specific adverse events were not available for the individual treatment groups, but the data dossier did not specify any differences between them. Methylphenidate transdermal system was found to have similar efficacy to immediate-release methylphenidate over 12 hours in a simulated classroom setting, starting 30 minutes after dosing. Differences in adverse events were not found between methylphenidate transdermal system and immediate-release methylphenidate. Nonstimulants Atomoxetine • Atomoxetine compared with methylphenidate o Evidence from 2 trials suggested that atomoxetine is associated with efficacy outcomes similar to immediate-release methylphenidate. However, in the smaller subgroup without prior stimulant exposure, the 2 drugs were not found to be statistically significantly different in response rates. Immediate-release clonidine • Current evidence does not clearly identify a difference in improvement of ADHD symptoms between immediate-release clonidine and immediate-release methylphenidate in children with ADHD (both with comorbid Tourette’s disorder and without). Inconsistency in some outcomes suggests caution in interpreting these results. Extended-release clonidine • No evidence directly comparing extended-release clonidine to another ADHD medication was found. Flexible dosing resulted in similar Attention deficit hyperactivity disorder 28 of 200 Final Update 4 Report Drug Effectiveness Review Project rates between placebo and clonidine groups. Somnolence and fatigue were more common in the clonidine groups than placebo, and peaked at 2 weeks. Immediate -release guanfacine No evidence directly comparing immediate-release guanfacine to another ADHD medication was found. Indirect evidence, based on a single small study with inconsistent findings, was insufficient to make conclusions. Extended-release guanfacine • No evidence directly comparing extended-release guanfacine to another ADHD medication was found. Duration of superiority over placebo based on teacher and parent ratings was apparent at 8 hours, but inconsistent across studies and outcomes at 12, 14, and 24 hours. Flexible dosing also resulted in higher rates of discontinuation than placebo. Rates of somnolence, fatigue, and headache were greater in the extended-release guanfacine groups than placebo. Adolescents • Adolescents were studied in a small number of short-term trials that involved immediate- ® release methylphenidate or methylphenidate OROS (Concerta ).